- Home
- DNLI vs TLRY Comparison
DNLI vs TLRY Comparison
Compare DNLI & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- TLRY
- Stock Information
- Founded
- DNLI 2013
- TLRY N/A
- Country
- DNLI United States
- TLRY Canada
- Employees
- DNLI N/A
- TLRY N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- DNLI Health Care
- TLRY Health Care
- Exchange
- DNLI Nasdaq
- TLRY Nasdaq
- Market Cap
- DNLI 2.1B
- TLRY 1.8B
- IPO Year
- DNLI 2017
- TLRY 2018
- Fundamental
- Price
- DNLI $15.42
- TLRY $1.62
- Analyst Decision
- DNLI Strong Buy
- TLRY Buy
- Analyst Count
- DNLI 15
- TLRY 4
- Target Price
- DNLI $33.50
- TLRY $1.58
- AVG Volume (30 Days)
- DNLI 2.1M
- TLRY 73.9M
- Earning Date
- DNLI 11-05-2025
- TLRY 10-09-2025
- Dividend Yield
- DNLI N/A
- TLRY N/A
- EPS Growth
- DNLI N/A
- TLRY N/A
- EPS
- DNLI N/A
- TLRY N/A
- Revenue
- DNLI N/A
- TLRY $821,309,000.00
- Revenue This Year
- DNLI N/A
- TLRY $6.66
- Revenue Next Year
- DNLI $95,463.19
- TLRY $4.75
- P/E Ratio
- DNLI N/A
- TLRY N/A
- Revenue Growth
- DNLI N/A
- TLRY 4.10
- 52 Week Low
- DNLI $10.57
- TLRY $0.35
- 52 Week High
- DNLI $33.33
- TLRY $1.88
- Technical
- Relative Strength Index (RSI)
- DNLI 62.72
- TLRY 63.07
- Support Level
- DNLI $12.58
- TLRY $1.14
- Resistance Level
- DNLI $15.75
- TLRY $1.88
- Average True Range (ATR)
- DNLI 0.68
- TLRY 0.14
- MACD
- DNLI 0.24
- TLRY 0.04
- Stochastic Oscillator
- DNLI 89.59
- TLRY 64.86
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.